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Abstract
Background
Injury to the airways after smoke inhalation is a major mortality risk factor in victims of burn
injuries, resulting in a 15–45% increase in patient deaths. Damage to the airways by smoke
may induce acute respiratory distress syndrome (ARDS), which is partly characterized by
hypoxemia in the airways. While ARDS has been associated with bacterial infection, the
impact of hypoxemia on airway microbiota is unknown. Our objective was to identify differ-
ences in microbiota within the airways of burn patients who develop hypoxemia early after
inhalation injury and those that do not using next-generation sequencing of bacterial 16S
rRNA genes.
Results
DNA was extracted from therapeutic bronchial washings of 48 patients performed within 72
hours of hospitalization for burn and inhalation injury at the North Carolina Jaycee Burn Cen-
ter. DNA was prepared for sequencing using a novel molecule tagging method and
sequenced on the Illumina MiSeq platform. Bacterial species were identified using the
MTToolbox pipeline. Patients with hypoxemia, as indicated by a PaO2/FiO2 ratio 300, had
a 30% increase in abundance of Streptococcaceae and Enterobacteriaceae and 84%
increase in Staphylococcaceae as compared to patients with a PaO2/FiO2 ratio > 300. Wil-
coxon rank-sum test identified significant enrichment in abundance of OTUs identified as
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Prevotella melaninogenica (p = 0.042), Corynebacterium (p = 0.037) and Mogibacterium (p
= 0.048). Linear discriminant effect size analysis (LefSe) confirmed significant enrichment of
Prevotella melaninognica among patients with a PaO2/FiO2 ratio 300 (p<0.05). These
results could not be explained by differences in antibiotic treatment.
Conclusions
The airway microbiota following burn and inhalation injury is altered in patients with a PaO2/
FiO2 ratio 300 early after injury. Enrichment of specific taxa in patients with a PaO2/FiO2
ratio 300 may indicate airway environment and patient changes that favor these microbes.
Longitudinal studies are necessary to identify stably colonizing taxa that play roles in hypox-
emia and ARDS pathogenesis.
Introduction
Smoke-induced inhalation injury occurs in up to 43% of burn victims, increasing death rates
by up to 20% as compared to patients with burn injury alone [1]. Inhalation injury predisposes
these patients to respiratory failure, acute respiratory distress syndrome (ARDS), and pneumo-
nia. Pneumonia, in combination with burn and inhalation injury, further increases patient
mortality to 60% and is a contributing risk factor to development of ARDS [2,3]. ARDS is a
life-threatening condition resulting from either direct or indirect injury to the lung, and is
diagnosed clinically by the presence of bilateral opacities on chest imaging and airway hypox-
emia [3,4]. Hypoxemia is determined by the ratio of the partial pressure of arterial oxygen
(PaO2) to the fraction of inspired oxygen (FiO2). To meet the Berlin definition of ARDS, this
ratio must be less than or equal to 300 mm Hg, with a minimum positive end expiratory pres-
sure (PEEP) of 5 cm H2O [4]. Although bacterial infection is frequently the first step towards
pneumonia and sepsis, and can induce direct injury to the lung and contribute to the patho-
genesis of ARDS, its relationship with the disease is complex and not well understood [5].
Early antibiotic therapy is critical to improved patient outcomes once infection and pneu-
monia occur, but identification of the organisms can be challenging [6]. Current methodolo-
gies rely on culture or polymerase chain reaction (PCR) techniques to identify the causative
agent [7]; however, these methods require specific knowledge of the organism’s growth and
metabolic requirements and a period of 1–2 days for identification and susceptibility testing,
which are prone to false positive results [7]. These limitations often result in broad-spectrum
antibiotic treatment that may have little impact on the target organism, promote the develop-
ment of antibiotic resistance, and ultimately increase mortality [6,7].
To address the limitation of organism identification, we utilized next-generation sequenc-
ing of bacterial 16S rRNA genes to characterize the bacterial communities (collectively known
as microbiota) in the airways of burn patients following smoke inhalation with or without a
PaO2/FiO2 ratio 300, regardless of the presence of ARDS. Study of the microbiota has
revealed the key roles they play in the development and function of the host immune system,
and how dysbiosis, or perturbation of the communities, contributes to disease [8–10].
Although host-microbiota interactions are complex and poorly understood, recent studies
underscore the importance of low-abundance species in dysbiosis and disease progression,
particularly in the airways [10,11]. We hypothesized that inhalation injury and a low P/F ratio
( 300) would create conditions within the airways that favor distinct communities of
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bacteria. We show that facultative anaerobic taxa are enriched among all burn patients, and
that specific, low-abundance bacterial taxa are associated with low P/F ratios within the first 24
to 72 hours after injury.
Methods
Patients and sample collection
Therapeutic bronchial washings from patients hospitalized for burn and inhalation injury at
the North Carolina Jaycee Burn Center were collected as previously described [12]. Briefly,
patients with suspected inhalation injury underwent clinically indicated bronchoscopy within
24 hours of admission. All patients were intubated, bronchial washes performed, and inhala-
tion injury severity scored on the basis of examination. Only those patients for whom inhala-
tion injury was confirmed by bronchoscopy were included in the present study. Only samples
taken within three days of injury were utilized. Clinical cultures were grown to detect bacteria
within these bronchoscopy samples. Organisms detected per patient and antibiotic treatment
are listed in S3 Table in the additional data. Differential cell counts were not done for the bron-
chial washings. According to the Berlin definition of ARDS, hypoxemia was defined as the
ratio of the partial pressure of arterial oxygen (PaO2) to the fraction of inspired oxygen (FiO2)
300 [4,12]. Ratios >300 were defined as normal oxygenation levels [3]. The P/F ratio for
each patient in this study was measured the same day the bronchial washing was done. Other
clinical information, such as patient demographics and total body surface area burned, were
collected upon admission. The study protocol was approved by the Institutional Review Board
at the University of North Carolina School of Medicine in Chapel Hill (IRB# 10–0959 and
#12–2475). All patients or their legally authorized representative gave written informed con-
sent for collection of their bronchial washings for inclusion in a repository as previously
described [12]. Analysis of the microbiota in bronchial washings was not an original part of
the study and was added after completion of sample collection (IRB #12–2475).
DNA extraction and sequencing
Bronchial washes were transported on ice and processed within 24–48 hours. DNA was
extracted from the cellular portion of the wash and quantified (online data supplement). Posi-
tive Staphylococcus aureus and negative reagent and human DNA controls were extracted
simultaneously and prepared in parallel with the patient samples for sequencing. Sequencing
of all DNA was performed in duplicate by a molecule tagging method recently described by
Lundberg et al., [13]. This approach allows us to confidently identify operational taxonomic
units (OTU) that diverge at the 3% threshold. Briefly, a short round of polymerase chain reac-
tion (PCR) was performed to attach molecule tags to each DNA molecule, followed by a round
of full PCR to label each individual sample with a barcode and attach the adapters necessary
for sequencing. The primers targeted the V4 region of the bacterial 16S rRNA gene with for-
ward sequence GTGCCAGCMGCCGCGGTAA (515F) and reverse sequence TAATCTWTGGGVH
CATCAGG (806R) [13]. Sequencing was performed on the Illumina MiSeq platform at the
High Throughput Sequencing Facility at the University of North Carolina at Chapel Hill.
Sequencing data and statistical analysis
We used the MTToolbox [14] pipeline to minimize sequencing errors and match reads to the
GreenGenes 16S rRNA database [15]. Sequences that did not match a 16S GreenGenes
sequence were removed from the OTU table and those remaining were corrected for variation
among 16S rRNA operon number. An R-squared read number correlation was performed on
Airway microbiota in burn patients with inhalation injury
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technical replicates in order to determine an appropriate threshold of low read count OTUs to
remove from the data [16]. This method improves reproducibility of the results while mini-
mizing loss of data. Total raw counts per OTU of duplicate patient samples were averaged and
count thresholds were set for the OTU tables using an R-squared correlation analysis as
detailed previously [16]. The samples varied according to the date of sequencing and thresh-
olds were set separately for each group (S1 and S2 Figs). Samples from patients with and with-
out hypoxemia were distributed among the sequencing plates as shown in S1 Table. OTU
tables with appropriate thresholds were imported into the program Explicet [17] for normali-
zation and subsequent diversity analyses and the Wilcoxon rank-sum and two-proportions
tests. Rarefaction was performed on sample counts within Explicet before bootstrapping to cal-
culate Chao1 diversity indices. The Wilcoxon test is a non-parametric, continuity-corrected
test appropriate for analysis of differential OTU abundances [17]. The two-proportions test
performs a continuity-adjusted chi-square test to determine differences in detection among
OTUs [17]. One-way analysis of variance (ANOVA) was used to identify differences among
the abundance of aerobic and anaerobic bacterial taxa present in patients with and without a
P/F ratio 300 (performed in R as anova = lm(Taxa_per_seq_count~Group, data = ALI))
[18]. The phyloseq package within R was used to create a principle components analysis
(PCA) plot to compare beta diversity across patients [19]. The linear discriminant analysis
(LDA) effect size (LEfSe) method [20] was used to determine the significance of differences in
taxa abundance by biologically relevant classes, which included patient P/F ratio and antibiotic
treatment. LEfSe first performs a factorial Kruskal-Wallis test to determine differential distri-
bution of OTUs among the biological classes. If subclasses are present, a pairwise Wilcoxon
test is done on those with p values greater than 0.05. OTUs with significant differences are
then used to build a linear discriminant analysis model, which uses the relative differences of
OTUs among classes to rank those that are most discriminative. To determine the influence of
antibiotic treatment and sequencing batch effect on these results, we performed a non-
parametric differential abundance analysis adjusted for antibiotic treatment and batch effects
[21].
Results
Patients
Of the 48 patients included in this study, 50% had P/F ratios 300 (Table 1). Of the 24 patients
with P/F ratios> 300, 7 subsequently had a P/F ratio < 300. All patients who did not survive
had initial P/F ratios < 300. The rate of positive bacterial cultures in both patients with (21%)
and without (25%) a P/F ratio 300 was similar to the overall rate (23%). However, the rate of
antibiotic treatment within the first 72 hours of injury in patients with a P/F ratio 300 was
lower (29%) than either patients with a higher P/F ratio (46%) or the entire group (40%). Anti-
biotic treatment was not associated with P/F ratio 300 (chi-square test, p = 0.4).
The airway microbiota among all patients
Among all patient samples, OTUs identified as facultative anaerobic taxa were detected at a
significantly higher rate than OTUs identified as either obligate anaerobic or obligate aerobic
taxa (Fig 1A; ANOVA p = 0.029). When we split the data by PaO2/FiO2 ratio, patients with
PaO2/FiO2 >300 contained more unique facultative anaerobic OTUs than those with PaO2/
FiO2 300, but this difference was not significant (Fig 1B). The most abundant OTUs among
all patient samples at the family level were Streptococcaceae and Enterobacteriaceae, which
accounted for 26% and 18% of total family-level OTUs, respectively. The remaining 56% of
OTUs consisted of 45 additional families, each present at 7% of the total family-level OTUs or
Airway microbiota in burn patients with inhalation injury
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less. Fig 2 shows the composition of the microbiota per patient for those with (Fig 2A) and
without (Fig 2B) hypoxemia. Positive and negative control samples were sequenced with the
patient samples and S2 Table quantifies the total reads and molecule tags produced and S3 Fig
shows the composition of these reads.
Enrichment of low-abundance OTUs among patients with PaO2/FiO2
300
The Streptococcaceae and Enterobacteriaceae family-level OTU abundances were not signifi-
cantly different between patients with and without PaO2/FiO2 300 (Wilcoxon test, p>0.05).
At the lowest level of OTU identification, Enterobacteriaceae family-level OTUs, Streptococcus
genus-level OTUs, and Staphylococcus genus-level OTUs were detected in 80% of patients both
with and without PaO2/FiO2 300 (Table 2; the average abundance refers to the percent of
each OTU within each group). However, when compared to patients with PaO2/FiO2 > 300,
patients with PaO2/FiO2 300 had a 27% increase in OTUs identified as Streptococcus spp., a
32% increase in Enterobacteriaceae, and an 83% increase in Staphylococcus spp, calculated as
the percent change. An additional six OTUs were detected in 80% of patients with PaO2/FiO2
 300 at 3.1% or less of the total OTUs in this group (Table 2). All OTUs detected in 80% of
patients were either facultative or obligate anaerobes. Figs 2 and 3 display OTU abundances at
the family level that account for greater than 1% of the total OTUs among individual patients
without and with PaO2/FiO2 300, respectively.
Alpha diversity among patients with and without PaO2/FiO2 300
The Chao1 diversity index, which is a non-parametric species richness estimator [22], did not
show significant differences in number of different OTUs between patients with and without
PaO2/FiO2 300 (Fig 3). Though the median Chao1 index in patients with PaO2/FiO2 > 300
is less than that of patients with PaO2/FiO2 300, it shows a much broader range in patients
with PaO2/FiO2 > 300.
Table 1. Patient clinical characteristics.
Clinical Variable Total PaO2/FiO2 300 PaO2/FiO2 > 300 T Test p Value
Patients 48 24 24 NA
Males 36 (75%) 18 (75%) 18 (75%) NA
Females 12 (25%) 6 (25%) 6 (25%) NA
BMI 27 (14–51) 30 (17–51) 25 (14–42) 0.1107
Age 41 (1–75) 42 (8–76) 41 (1–75) 0.8143
%TBSA 19 (0–85) 27 (0–85) 10 (0–40) 0.002
Antibiotic Treated 18 (40%) 7 (29%) 11 (46%) 0.3711¶
Baux Score 60 (1–115) 71 (31–115) 50 (1–96) 0.0109
Endotracheal Tube 29 (60%) 17 (71%) 12 (50%) 0.3099¶
Days on Ventilator 35 (0–105) 45 (0–105) 25 (0–79) 0.0136
Positive Cultures 11 (23%) 5 (21%) 6 (25%) 0.894¶
Survived 41 (87%) 17 (71%)* 24 (100%) 0.02497¶
Patient clinical characteristics were grouped by total population and subdivided by P/F ratio. The data are represented as mean (range) or number
(percent). PaO2/FiO2 > 300 and PaO2/FiO2 300 group percentages are calculated per group total.
*Cause of death was either or both cardiac and pulmonary failure.
¶Indicates the p value from Pearson’s chi-squared test.
%TBSA = percent total body surface area burn.
https://doi.org/10.1371/journal.pone.0173848.t001
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Fig 1. Increased detection of unique facultative anaerobic taxa. (A) Unique facultative anaerobic OTUs were detected significantly
more frequently than obligate aerobes or anaerobes among all patients. (B) No significant difference was found between number of
unique facultative anaerobic OTUs when the data was split by patient PaO2/FiO2 ratio. OTUs were identified as facultative anaerobes,
obligate anaerobes, or obligate aerobes among all patients. OTUs were quantified and normalized to the molecule tag count and
averaged by bacterial aerobic or anaerobic capability. One-way ANOVA detected a significant difference among the mean taxa of
facultative anaerobes (p = 0.029). (n = 48)
https://doi.org/10.1371/journal.pone.0173848.g001
Airway microbiota in burn patients with inhalation injury
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Beta diversity among patients with and without PaO2/FiO2 300
The PCA plot in Fig 4 displays similarity of microbiota among burn patients with inhalation
injury. Data points represent individual patients, which are colored by PaO2/FiO2 ratio. The
shape of each data point represents whether P. melaninogenica was detected in the community.
Patients with PaO2/FiO2 ratios> 300 with P. melaninogenica present cluster to the left above
Fig 2. Patient airway microbiota composition. OTUs identified as the families Streptococcaceae and Enterobacteriaceae dominate the airway
microbiota within 72 hours following burn and inhalation injury. (A) The microbiota composition among patients with hypoxemia. (B) The microbiota
composition among patients without hypoxemia. Each horizontal bar represents an individual patient microbiota normalized to 100%. Different colored
sections within each bar indicate abundance of specific families. The category ‘Other’ includes bacterial taxa present at less than 1% of the total
community. (n = 24)
https://doi.org/10.1371/journal.pone.0173848.g002
Table 2. Average abundance of taxa detected among 80% of patients.
Bacteria Aerobe/
Anaerobe
Average Abundance Among Patients with
PaO2/FiO2 > 300*
Average Abundance Among Patients with
PaO2/FiO2 300§
OTU10: Enterobacteriaceae Facultative
anaerobe
20.0 17.0
OTU75: Streptococcus spp. Facultative
anaerobe
27.8 22.1
OTU58: Staphylococcus spp Facultative
anaerobe
2.7 9.2
OTU35: Atopobium spp. Facultative
anaerobe
NA 3.1
OTU62: Gemellaceae Facultative
anaerobe
NA 1.8
OTU108: Veillonella dispar Obligate
anaerobe
NA 1.2
OTU65: Lactobacillales Facultative
anaerobe
NA 0.7
OTU45: Prevotella spp. Obligate
anaerobe
NA 2.4
OTU47: Prevotella
melaninogenica
Obligate
anaerobe
NA 2.5
Taxa detected in 80% of patients with and without PaO2/FiO2 300. Taxa names represent the lowest level of identification of the corresponding OTU.
*Percent of total OTUs among 24 patients with PaO2/FiO2 > 300.
§Percent of total OTUs among 24 patients with PaO2/FiO2 300.
NA indicates that these OTUs were not present among 80% of patients with PaO2/FiO2 > 300.
https://doi.org/10.1371/journal.pone.0173848.t002
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the horizontal zero axis on the graph, while those with PaO2/FiO2 ratios < 300 with P. melani-
nogenica cluster to the left below it. Patients with PaO2/FiO2 ratios > 300 without P. melanino-
genica are more spread out along the right side of the graph while those with PaO2/FiO2
ratios< 300 and without P. melaninogenica are scattered throughout. This clustering pattern
suggests that the presence of P. melaninogenica is associated with microbiota similarity regard-
less of PaO2/FiO2 ratio, while in the absence of this microbe a PaO2/FiO2 ratio higher than 300
may influence similarity. Low PaO2/FiO2 ratio without P. melaninogenica does not appear to
be associated with microbiota similarity.
Significant enrichment of specific OTUs among patients with PaO2/FiO2
 300
Four OTUs were identified as significantly different in abundance and detection between
patients with and without PaO2/FiO2 300. OTUs identified as Prevotella melaninogenica,
Fig 3. Chao1 diversity among patients with and without hypoxemia. Samples were rarefied prior to calculation of the Chao1 diversity
index and averaged based on PaO2/FiO2 ratio. Student’s T test did not show significant differences between the patient groups. (n = 48)
https://doi.org/10.1371/journal.pone.0173848.g003
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Mogibacterium spp., and Corynebacterium spp. were significantly increased in abundance
among patients with PaO2/FiO2 300 (Table 3). Patients with PaO2/FiO2 300 had 72%
more of the OTU represented by Prevotella melaninogenica than patients with ratios > 300,
79% more Corynebacterium genus-level OTU, and 86% more of the Mogibacterium genus-
level OTU. Prevotella melaninogenica OTUs were also detected significantly more frequently
Fig 4. Clustering by principle components analysis suggests microbiota similarity in the presence of P. melaninogenica. The
R package phyloseq was used to generate a PCA plot of patient microbiota abundance. Patient samples containing P. melaninogenica
cluster to the left side of the graph and are split based on PaO2/FiO2 ratio. Manhattan distance was used to perform the ordination prior
to plotting the PCA graph. Data points are colored by patient PaO2/FiO2 ratio (Red: P/F < 300; Green: P/F > 300) and data point shape
indicates presence (square) or absence (triangle) of P. melaninogenica. Control samples are included for comparison (blue circles).
(n = 48).
https://doi.org/10.1371/journal.pone.0173848.g004
Airway microbiota in burn patients with inhalation injury
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among patients with PaO2/FiO2 300, while Corynebacterium OTUs were significantly more
frequent in patients with ratios > 300 (Table 4). OTUs identified as Fusobacterium spp. were
also detected significantly more frequently among patients with PaO2/FiO2 300. LEfSe [20]
was used to confirm these results. LEfSe identified the Prevotella melaninogenica OTU as most
discriminative among patients with PaO2/FiO2 300 as compared to those with ratios> 300,
followed by Staphylococcus genus-level and then Bifidobacteriales order-level OTUs (Fig 5A).
Though Staphylococcus OTUs are more abundant among the patients (Fig 6A), their average
abundance within patients with hypoxemia is less than that of P. melaninogenica (Fig 6B). Pre-
votella is consistently present among the patients (Fig 6A) and its average abundance in
patients with hypoxemia is greater than that for the other two significantly enriched taxa (Fig
6B). Additional analysis with LEfSe indicated significant enrichment of Staphylococcus spp.
OTUs in the presence of antibiotics, while enrichment of Prevotella melaninogenica OTUs was
not affected (Fig 5B and 5C). Among all patients in the study, LEfSe identified significant
enrichment of taxa only in patients with hypoxemia (Fig 5A). Among only patients with hyp-
oxemia, LEfSe found significant enrichment of taxa only in patients treated with antibiotics
(Fig 5B). LEfSe identified significant enrichment of taxa in patients that did and did not receive
antibiotics when all patients were included in the analysis (Fig 5C). Among patients without
hypoxemia, several bacterial taxa were enriched with and without antibiotic treatment (S5
Fig). Non-parametric differential abundance analysis adjusted for antibiotic treatment and
sequencing batch effect confirmed that enrichment of P. melaninogenica was not affected by
antibiotic treatment or batch effect.
Discussion
Our work details differences in the airway microbiota in patients with PaO2/ FiO2 ratios 300
and> 300, following burn and inhalation injury. A cut-off of 300 was chosen based on the
Table 3. Percent abundance OTU level differences.
Taxa Percent Abundance Among Patients with PaO2/
FiO2 300
Percent Abundance Among Patients with PaO2/
FiO2 > 300
P-Value
OTU47: Prevotella
melaninogenica
1.56 (0.04) 0.44 (7.7x10-3) 0.042
OTU18: Corynebacterium spp. 1.53 (0) 0.32 (1.8x10-3) 0.037
OTU82: Mogibacterium spp. 0.07 (1.0x10-3) 0.01 (1.3x10-4) 0.048
OTU level significant differences in abundance as determined by Wilcoxon rank-sum test. Taxa names represent the lowest level of identification of the
corresponding OTU. Values are percent abundance (interquartile range).
https://doi.org/10.1371/journal.pone.0173848.t003
Table 4. OTU level detection differences.
Taxa Detection Rate Among Patients with PaO2/FiO2
300 (# of patients)
Detection Rate Among Patients with PaO2/FiO2 >
300 (# of patients)
P-Value
OTU47: Prevotella
melaninogenica
19 11 0.037
OTU18: Corynebacterium
spp.
6 14 0.040
OTU115: Fusobacterium spp. 17 9 0.043
OTU level significant differences in detection as determined by the two-proportions test. Taxa names represent the lowest level of identification of the
corresponding OTU.
https://doi.org/10.1371/journal.pone.0173848.t004
Airway microbiota in burn patients with inhalation injury
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Berlin definition of airway hypoxemia in ARDS [4]. We identify several low-abundance OTUs
with significant enrichment in patients with PaO2/FiO2 300, of which the OTU identified as
Prevotella melaninogenica was the most significant. In addition, we show that while antibiotic
treatment alters the airway microbiota, it does not explain the enrichment of a specific OTU
among patients with PaO2/FiO2 300.
Patients with a PaO2/ FiO2 ratio that was less than or equal to 300 within 72 hours of burn
and inhalation injury had consistently worse indicators of poor prognosis. Table 1 shows the
average values for patients with and without PaO2/FiO2 300 for several clinical variables that
are predictive of injury severity. In patients with inhalation injury, several studies have demon-
strated that age, percent TBSA and PaO2/ FiO2 ratio predict mortality [2]. The PaO2/ FiO2
ratio itself has been shown to be more predictive of patient outcomes on the day after patients
Fig 5. Significant enrichment of specific taxa. Specific bacterial taxa are enriched among patients with PaO2/FiO2 300. (A) LEfSe analysis detected
significant enrichment of OTUs identified as Prevotella melaninogenica, Staphylococcus spp., and the order Bifidobacteriales among patients with
hypoxemia. No significant enrichment was detected among patients without hypoxemia. (B) Among only those patients with hypoxemia, only those not
treated with antibiotics contained significantly enriched taxa, all of which were in the Streptococcaceae family. No significant enrichment of taxa was
detected among patients not treated with antibiotics in this comparison. (C) Antibiotic treatment alters the microbiota among all patients, with a specific
increase in Staphylococcus among patients treated with antibiotics, but does not impact association of the Prevotella melaninogenica OTU with
hypoxemia. LEfSe uses a Kruskal-Wallis rank-sum test, Wilcoxon rank-sum test, and linear discriminant analysis to determine the biological relevance of
significant enrichment of taxa and ranks them by effect size. LDA score indicates the magnitude of the effect size.
https://doi.org/10.1371/journal.pone.0173848.g005
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meet the Berlin definition of ARDS rather than the day of [23]. In our study, patients with
PaO2/FiO2 300 within 72 hours of injury had, on average, a higher Baux score (age + %
TBSA), spent longer on the ventilator, were intubated more frequently, and had lower survival
rates. Only percent TBSA and the PaO2/ FiO2 ratio were significantly different among the
patient groups (Student’s t test, p = 0.002 and 5.293e-11, respectively). Patients were 41 years
old on average, but ranged from 1 to 75 years. Though not statistically more prevalent in this
cohort, patients at the ends of this spectrum are more susceptible to infection, pneumonia, and
poor outcomes [24]. Over a lifetime, a patient will range from increased susceptibility to infec-
tion after burn and inhalation injury, to decreased susceptibility in mid-life, to increased in old
age. While fewer patients with PaO2/FiO2 300 received antibiotic treatment than those with
ratios> 300, rates of positive clinical bacterial cultures were similar between the two groups.
This discrepancy may be partly due to the challenges in predicting bacterial infection and
development of pneumonia in this patient population. Pneumonia is the primary complication
of inhalation injury [25] and early, adequate antibiotic treatment has been shown to improve
outcomes in these patients [6]. Criteria to predict pneumonia early after injury have been
developed and include age> 60 years, TBSA> 20%, and initial PaO2/ FiO2 ratio of 300
[26]. The patients with PaO2/FiO2 300 in our study meet the TBSA and initial PaO2/ FiO2
ratio criteria, but not the age criteria, which may explain why they did not receive as many
antibiotics. A major limitation of this scoring system is its failure to take into account bacteria
within the airways, emphasizing the need for one that does, perhaps through a combination of
clinical cultures and next-generation sequencing of bacterial 16S rRNA genes.
Fig 6. Percent abundance of OTUs with significant enrichment detected by LEfSe. Of the three taxa LEfSe identified as significantly enriched in
patients with hypoxemia, Staphylococcus had the highest percent increase in abundance. However, Prevotella melaninogenica was more consistently
present among patients with hypoxemia, resulting in its higher ranking over Staphylococcus spp. (A) Bacterial abundances for taxa identified as
significantly enriched by LEfSe are displayed per patient. The X axis is labeled with each patient’s PaO2/FiO2 ratio and the Y axis displays relative
abundance of the taxa. (B) The range of abundances of the three significantly enriched taxa are split by patient hypoxemia status along the X axis.
(n = 48).
https://doi.org/10.1371/journal.pone.0173848.g006
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Though we have focused on the PaO2/FiO2 ratio in alterations of the airway microbiota,
TBSA may also contribute to the differences we detected. Increasing TBSA is a known predic-
tor of patient mortality [25], which is compounded in the presence of inhalation injury. Burns
greater than 20% TBSA induce systemic changes similar to those seen in trauma and surgical
patients [27]. The injury induces a systemic inflammatory response, but compromises global
immune function, increasing susceptibility to bacterial, viral, and fungal infections. Patients
with PaO2/FiO2 300 in our study had, on average, 27% TBSA, indicating immune dysfunc-
tion that could predispose them to airway bacterial colonization and infection. Though we
cannot determine whether the burn injury itself induces PaO2/FiO2 300 through systemic
changes or if this is a direct result of inhalation injury, it is clear that TBSA may be contribut-
ing indirectly to alterations in the airway microbiota in our patient population. A mouse
model of burn and inhalation injury is necessary to determine the extent to which TBSA influ-
ences changes in the airway microbiota.
Among all patients in the study, there were significantly more unique OTUs identified as
facultative anaerobes than either strict anaerobes or aerobes (Fig 1A). Anaerobic taxa are nor-
mally associated with mucosal surfaces, but may lead to infection following disruption by
trauma and surgery [28]. All patients within this study, regardless of PaO2/FiO2 ratio, presum-
ably experienced disruption of their mucosa through the double trauma of burn and inhalation
injury. Recent work has demonstrated that the mouth serves as the primary source community
for the airway microbiota [29]. Inhalation injury may have increased microbial immigration
through disruption of the mouth and upper airways’ mucosal surface, dislodging taxa that sub-
sequently traveled down the airways to the bronchi. Alteration of airway conditions by inhala-
tion injury may have selected for enrichment of facultative anaerobic taxa among all patients,
which was significantly different from strict aerobic and anaerobic taxa (ANOVA, p = 0.029).
When we subdivided the data by PaO2/FiO2 ratio, we did not see significant differences in
strict aerobes, anaerobes or facultative anaerobes between the two patient groups (Fig 1B,
p> 0.05). These results suggest that PaO2/FiO2 300 early after burn and inhalation injury
does not select for overall taxa in the airways based on their aerobic or anaerobic capabilities,
but that burn and inhalation injury do. Development of PaO2/FiO2 300 within 72 hours of
burn and inhalation injury may not be enough time to observe significant change in the abun-
dances of overall taxa between the two groups.
We detected OTUs identified as Enterobacteriaceae, Streptococcus spp., and Staphylococcus
spp. in 80% of patients with and without PaO2/FiO2 300 (Table 2). All three of these OTUs
are facultative anaerobes and their dominance across patients implies similarity in the mecha-
nism of injury to the airways selecting for these taxa and their related functions. Inhalation
injury may induce fluctuations in oxygen availability in the airways, perhaps creating both aer-
obic and anaerobic microenvironments that favor taxa that can withstand these changes. Our
finding of overall significant enrichment of facultative anaerobic taxa supports this idea.
Patients with PaO2/FiO2 300 demonstrated a 32%, 27%, and 83% increase in Enterobacteria-
ceae, Streptococcus spp., and Staphylococcus spp. OTUs, respectively, when compared to those
with PaO2/FiO2 > 300 (Table 2). Additionally, 80% of patients with PaO2/FiO2 300 con-
tained six more OTUs that represented 3.1% and less of the total community among these
patients (Table 2). This suggests that, although facultative anaerobes are enriched over strict
anaerobes and aerobes among all patients, there are differences in enrichment of specific, low-
abundance OTUs depending on PaO2/FiO2 ratio.
Enterobacteriaceae, Streptococcus spp., and Staphylococcus spp. have all been consistently
detected in previous airway microbiome studies in both healthy and diseased airways [30].
Members of the Enterobacteriaceae family have been implicated in inflammation-driven colo-
rectal cancer in the gut microbiome [31,32], are enriched in patients with COPD and asthma,
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but can also be detected in healthy airways [33–35]. Similarly, Streptococcus is consistently
found in healthy airways but is enriched in COPD [35], idiopathic pulmonary fibrosis (IPF)
[36], and pneumonia [37]. Staphylococcus, while a normal commensal in the nasal microbiome
[38,39], is largely associated with disease in the lung, such as IPF [36], and cystic fibrosis, in
which it is correlated with increased inflammation [40,41]. Given the inconsistency with
which these three taxa are associated with health or disease, it is difficult to interpret the
importance of their detection across patients with and without PaO2/FiO2 300. They may
indicate an underlying core airway microbiota among all burn and inhalation injury patients
but it is not clear whether their presence is beneficial or detrimental. Given that sampling was
done within 72 hours of injury, some of the taxa we have detected could be acquired nosoco-
mial pathogens rather than commensal organisms, implying a detrimental impact. A longitu-
dinal study of patients with burn and inhalation injury could clarify the role of these taxa.
Due to its association with health outcomes, overall diversity has long been a focus in many
microbiome studies; however, we observed no difference in alpha diversity between patients
with PaO2/FiO2 300 and those with PaO2/FiO2 > 300 (Fig 3). Despite this, the PCA plot in
Fig 4 suggests similarity in the microbiota between patients depending first on whether P. mel-
aninogenica is present and then on patient PaO2/FiO2 ratio. Patients with P. melaninogenica
clustered to the left side of the graph and were largely split by PaO2/FiO2 ratio. Patients with-
out P. melaninogenica and PaO2/FiO2 ratio > 300 tended to cluster together, but those without
this microbe and PaO2/FiO2 ratio < 300 were scattered throughout the graph. This agrees
with recent studies demonstrating that diversity (especially in the airways) is a complex, multi-
factorial trait that encompasses more than an indication of positive or negative outcomes
[34,41]. Many of these studies have emphasized the critical roles of specific taxa during disease
and their interactions with other taxa [10,11]. They suggest that rare and less abundant taxa,
which are overlooked by traditional culture methods, may play significant roles in the develop-
ment of disease. Dysbiosis of the microbiota is followed by enrichment of a specific bacterial
taxa that is either rarely found or present at very low abundance [10,37]. Changes in the bal-
ance of bacterial taxa alters how the microbes interact with each other along with their associ-
ated functions, allowing species that may have been suppressed by the presence of other
bacteria to overgrow [10]. What was considered a harmless commensal in a healthy individual
may become a harmful pathogen under dysbiosis-inducing conditions [42]. Accordingly, in
our study, we observed significant differences not in the species dominating the overall com-
munity, but in less abundant taxa. While these taxa do not differ in microbial diversity between
patient groups, they may differ by functional diversity, which ultimately plays a greater role in
patient outcomes [30]. Most significantly, we identified enrichment of the OTU Prevotella mel-
aninogenica among patients with PaO2/FiO2 300 within 72 hours of burn and inhalation
injury (Fig 5A).
Prevotella melaninogenica is a gram-negative obligate anaerobe that is part of the normal
microbiota but is also a significant source of infection [43]. The specifics of Prevotella melani-
nogenica’s function in the microbiome remain unclear. In the gut, it has been identified as a
normal commensal family, but within dental plaque it is a potential pathogen [44]. In the
upper airways, the presence of Prevotella melaninogenica is associated with health while lacto-
bacilli, Rothia spp., and Streptococcus pneumoniae dominate bacterial profiles in patients with
pneumonia [37]. Prevotella melaninogenica’s positive role in the airways is supported by its
ability to decrease production of T cell-activating IL-12p70 by dendritic cells exposed to Hae-
mophilus influenzae [45]. This highlights the ability of bacteria within microbial communities
to regulate each other’s functions as well as that of the host immune system. Several studies
indicate that Prevotella melaninogenica could also play a non-beneficial or harmful role in the
airways under certain conditions. Prevotella melaninogenica was a dominant bacterial species
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isolated from the airways of intubated patients [46] as well as cystic fibrosis (CF) patients,
where characterized species varied phenotypically over time [47]. Prevotella species in CF air-
ways have been shown to be virulent and contribute to the pathophysiology of the disease [48].
Prevotella melaninogenica specifically produces short-chain fatty acids that generate IL-8 pro-
duction by host epithelial cells, presumably drawing neutrophils to the airways that contribute
to the inflammatory status of the patient [49]. Though present at low abundance, we identified
a consistent and significant enrichment of the Prevotella melaninogenica OTU among patients
with PaO2/FiO2 300 within 72 hours of burn and inhalation injury. While facultative anaer-
obic taxa were enriched among all patients in the study, Prevotella melaninogenica was
enriched specifically in patients whose airways have the lowest PaO2/FiO2 ratio, which may
select for growth of this obligate anaerobe. Without pre-injury samples from the patients, it is
not possible to determine whether enrichment of Prevotella melaninogenica precedes PaO2/
FiO2 300 or if a low PaO2/FiO2 ratio precedes this enrichment. If confirmed in a longitudi-
nal study, the consistent presence of this OTU throughout the hospital stay of patients with
PaO2/FiO2 300 would suggest that it is in some way altering the airway environment to
favor Prevotella melaninogenica. This could be achieved through elimination of other OTUs
that Prevotella melaninogenica interacts with that cannot thrive in hypoxic conditions or out-
growth of those that can. Early changes in both oxygen availability and other OTUs may
impact Prevotella melaninogenica’s ability to act as a pathogen depending on whether species it
interacts with are increased or eliminated or airway conditions alter its growth and pathoge-
nicity. Given that Prevotella melaninogenica is an obligate anaerobe, hypoxic conditions may
favor its growth, but it is impossible to predict its pathogenicity without further study. While
determining a causal link between PaO2/FiO2 300 and Prevotella melaninogenica is beyond
the scope of the current study, future studies will examine its pathogenicity from patients with
and without PaO2/FiO2 300 as well as its role in either preceding or following hypoxemia.
Infection is a serious concern in these immunocompromised patients, for whom mortality
rates increase to 20% with inhalation injury alone and triple to 60% when present with pneu-
monia [50]. Prophylactic antibiotic treatment is a common strategy to prevent infection, but
results in as many as 25% of patients without infections receiving antibiotics [51], which may
alter the microbiota in deleterious ways and encourage outgrowth of resistant bacteria [52].
Antibiotic treatment has been shown to perturb the gut microbiome and immune cell
response by eliminating commensal species and allowing drug-resistant bacteria to take over
[53,54]. In the airways, antibiotic treatment in asthma shows a similar response, in which elim-
ination of certain species provides a niche for establishment of other infectious species [55]. In
COPD, three months of varying types of antibiotic treatment in patients did not reduce overall
bacterial load but instead increased antibiotic resistance across all groups [56]. While a power-
ful tool for controlling bacterial growth, antibiotic treatment is a double-edged sword that can
create communities of bacteria resistant to treatment. Our poor understanding of bacterial
interactions within the microbiota and their roles in patient outcomes combined with antibiot-
ics’ lack of specificity results in overkilling of beneficial organisms that could aid in improving
patient outcomes. In our study, 18 total patients were treated with antibiotics; 9 of these had
negative culture results and for 2, cultures were not done (S3 Table). If negative culture results
indicate absence of infection in these patients, antibiotic treatment is unnecessarily altering
the airway microbiota, possibly contributing to development of resistance and poor outcomes.
Among all patients treated with antibiotics, analysis with LEfSe indicated significant enrich-
ment of bacteria in the Staphylococcaceae family and the order Bacillales (Fig 5C). These bacte-
ria may be resistant to the drugs or not targeted by them, leading to overgrowth of these
particular species. Methicillin-resistant Staphylococcus aureus is a known problematic infection
in hospitals, including the Jaycee Burn Center, but its role within burn patient microbiota is
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unknown and requires further study. Despite alteration of other taxa by antibiotic treatment,
enrichment with the Prevotella melaninogenica OTU among patients with PaO2/FiO2 300
was not affected, implying that its association with hypoxemia is independent of antibiotic
treatment, at least within 72 hours of injury (Fig 5B and 5C). Further study is necessary to
determine the role of this OTU in early development of hypoxemia and whether targeted anti-
biotic treatment may be beneficial.
There are several limitations to the study. Although unique in its examination of a heteroge-
neous group of burn patients, our work is also limited by this variability. The heterogeneity of
clinical diagnoses in this group makes interpretation of results challenging. We were unable to
extract significantly more DNA from healthy human bronchial washings than we did from our
negative reagent controls, and therefore were unable to include healthy control samples for
comparison (S4 Fig). However, the number of patients studied is comparable to or larger than
previous studies of microbiota in airway disease [10,35]. Longitudinal samples were taken
throughout the course of each patient’s hospital stay, but the variation in drug treatments
(including antibiotics) and therapies precluded achievement of statistical significance among
the microbiota detected in these samples. Despite these limitations, this study is pioneering in
its examination of the injured airway microbiota among burn patients and its association with
patient outcomes.
In conclusion, we have demonstrated differences in the airway microbiota of patients with
and without PaO2/FiO2 300 within 72 hours of burn and inhalation injury. We detected
overall enrichment of facultative anaerobes among all patients with differences in specific
OTUs among patients with and without PaO2/FiO2 300. Significant differences between
these patients reside among the less abundant OTUs, specifically the Prevotella melaninogenica
OTU, an obligate anaerobe whose role in the microbiome is unclear. Hypoxic conditions
indicative of ARDS development may favor Prevotella melaninogenica enrichment and alter its
pathogenicity. Alternatively, hypoxemia may develop due to increased abundance of this OTU
following inhalation injury. A mouse model of inhalation injury is needed to determine
whether development of hypoxemia drives enrichment of Prevotella melaninogenica or enrich-
ment of this OTU induces hypoxemia. Given the cross-sectional nature of this study, more
work is necessary to determine the long-term impact of Prevotella melaninogenica and its role
in the airway microbiome of burn patients with inhalation injury who develop PaO2/FiO2
300 within 72 hours of injury. Importantly, antibiotic treatment did not alter this association,
supporting a link between this OTU and PaO2/FiO2 300 early after burn and inhalation
injury.
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S1 Fig. Technical replicate comparison to determine sample groups for count threshold
setting. Variability was minimized by grouping samples by the plate on which they were
sequenced. The Y axis displays log10 transformed raw read counts per OTU for the first repli-
cate and the X axis displays these values for the second replicate. (A) Log10 transformed raw
counts per OTU from Plate 2, samples sequenced January 2015. (B) Log10 transformed raw
counts per OTU from Plate 1, samples sequenced January 2015. (C) Log10 transformed raw
counts per OTU from Plate 3, samples sequenced December 2014.
(TIF)
S2 Fig. R-squared correlation of the progressive drop-out analysis used to set count thresh-
olds by plate on which the samples were sequenced. The threshold for log10 transformed
raw counts per OTU per sequencing batch was set where the regression began to plateau (red
line), indicating acceptable levels of read count correlation between the replicate samples. (A)
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for raw counts for samples on Plate 1, samples sequenced January 2015. (C) R2 values for raw
counts for samples on Plate 3, samples sequenced December 2014.
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S3 Fig. Percent abundance of control OTUs. Each bar represents OTUs detected among
human (16HBE), Staphylococcus aureus (SAUR), and reagent (CNTRL) DNA controls normal-
ized to 100%. n = 6
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S4 Fig. No significant detection of bacterial DNA in healthy airway controls. Bronchoscopy
was performed on healthy volunteers and DNA was extracted from airway washings in the
same manner as the burn patient samples. Extracted DNA was quantified using the universal
primer set developed by Maeda et. al. DNA extracted from Staphylococcus aureus and Klebsiella
pneumoniae were used as positive controls and DNA from the human cell line 16HBE was
used as a negative control. A water-only reagent control was included as well. DNA extracted
from six healthy volunteers did not contain significantly more DNA than the negative control.
(n = 6).
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S5 Fig. Significant enrichment of taxa among patients without hypoxemia in the presence
or absence of antibiotic treatment. Specific taxa are enriched among non-hypoxemic patients
who did and did not receive antibiotics. Analysis with LEfSe detects significant enrichment of
bacteria in the Enterobacteriales order with antibiotic treatment, while several other taxa were
enriched without treatment.
(TIF)
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